Corrigendum to "WCN24-1897 MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE AND MONOCLONAL IMMUNOGLOBULIN RELATED KIDNEY DAMAGE IN B-CELL MALIGNANCIES: THE REAL CLINICAL PRACTICE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S624-S625].
對於「WCN24-1897 MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE AND MONOCLONAL IMMUNOGLOBULIN RELATED KIDNEY DAMAGE IN B-CELL MALIGNANCIES: THE REAL CLINICAL PRACTICE」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,頁S624-S625]。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S86].
對於「WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,第S86頁]。
Kidney Int Rep 2024-07-31
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 6, Issue 4, April 2021, Pages 1183-1188].
對於「Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy」的更正 [<i>Kidney International Reports</i> 第6卷,第4期,2021年4月,頁1183-1188]。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-1924 SOCIODEMOGRAPHIC AND CLINICAL PROFILE OF OLDER ADULTS IN A HEMODIALYSIS UNIT IN NORTHEASTERN BRAZIL: CHALLENGES AND PERSPECTIVES" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S282-S283].
對於「WCN24-1924 巴西東北部血液透析單位老年人的社會人口學和臨床特徵:挑戰與展望」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,頁S282-S283]。
Kidney Int Rep 2024-08-19
Corrigendum to "WCN24-658 Comparative Analysis of Zwitterionic Materials and Polyvinyl Pyrrolidone for Enhancing Dialysis Membrane Hemocompatibility and Psychological Symptoms in Patients" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S362-S363].
對於「WCN24-658 比較分析 Zwitterionic 材料和聚乙烯吡咯烷酮以增強透析膜的血液相容性及患者的心理症狀」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,頁S362-S363]。
Kidney Int Rep 2024-08-19
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容,或是有其他相關的問題,請提供更多細節!
PubMedDOI
Corrigendum to "WCN24-660 Comparative Analysis of High Flux and Low Flux Dialysis Membranes: In-Situ Synchrotron Imaging and Experimental Ex-Vivo Studies" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S363].
對於「WCN24-660 高通量與低通量透析膜的比較分析:原位同步輻射成像及實驗性體外研究」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,第S363頁]。
Kidney Int Rep 2024-08-19
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容,或是有其他相關的問題,請提供更多細節!
PubMedDOI
Corrigendum to "WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369].
對於「WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,頁S368-S369]。
Kidney Int Rep 2024-08-19
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容,或是其他相關的問題,請提供更多細節!
PubMedDOI
Corrigendum to "WCN24-465 RISK OF MORTALITY IN PATIENTS RECEIVING HIGH-VOLUME ONLINE HEMODIAFILTRATION (OL-HDF) VERSUS HIGH-FLOW HEMODIALYSIS (HD) THERAPY IN 14 FRESENIUS MEDICAL CARE ECUADOR (FMC) CLINICS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S359].
對於「WCN24-465 高容量線上血液透析 (OL-HDF) 與高流量血液透析 (HD) 治療在 14 家 Fresenius Medical Care Ecuador (FMC) 診所中患者死亡風險的比較」的更正 [<i>Kidney International Reports</i> 第 9 卷,第 4 期,補充,2024 年 4 月,第 S359 頁]。
Kidney Int Rep 2024-08-19
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容,或是其他相關資訊,請提供更多細節!
PubMedDOI
Corrigendum to "WCN24-1709 NON-CADAVERIC HOMOLOGOUS VEIN AS VASCULAR ACCESS IN A PATIENT WITH EXHAUSTED NATIVE VEINS ON HEMODIALYSIS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S398-S399].
對於「WCN24-1709 非屍體同源靜脈作為一名在透析中原生靜脈耗竭患者的血管通路」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,頁S398-S399]。
Kidney Int Rep 2024-08-19
Corrigendum to "WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S541].
對於「WCN24-2499 CAVEOLIN-1 和 CAVEOLIN-2 作為急性膽汁淤積大鼠腎損傷的潛在尿液早期生物標記」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,第S541頁]。
Kidney Int Rep 2024-08-19